Gender differences in the clinical features of hypertrophic cardiomyopathy caused by cardiac myosin-binding protein C gene mutations

Journal of Cardiology

Volumn 65, Issue 5, 2015, Pages 423-428

  Terauchi, Yasunobu ^a   Kubo, Toru ^a   Baba, Yuichi ^a   Hirota, Takayoshi ^a   Tanioka, Katsutoshi ^a   Yamasaki, Naohito ^a   Furuno, Takashi ^a   Kitaoka, Hiroaki ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

Gender differences; Hypertrophic cardiomyopathy; Sarcomere mutations

Indexed keywords

CARDIAC MYOSIN BINDING PROTEIN C; MYOSIN BINDING PROTEIN C; UNCLASSIFIED DRUG; CARRIER PROTEIN; MYOSIN-BINDING PROTEIN C;

ADULT; ARTICLE; CHRONIC ATRIAL FIBRILLATION; CLINICAL FEATURE; CONTROLLED STUDY; DOPPLER ECHOCARDIOGRAPHY; ECG ABNORMALITY; FEMALE; FOLLOW UP; GENE MUTATION; GENOTYPE; HEART FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; INCIDENTAL FINDING; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NEW YORK HEART ASSOCIATION CLASS; PAROXYSMAL ATRIAL FIBRILLATION; PENETRANCE; PHENOTYPE; SEX DIFFERENCE; SYSTOLIC HEART MURMUR; AGE; AGED; COMPARATIVE STUDY; GENETICS; INCIDENCE; KAPLAN MEIER METHOD; MORTALITY; MUTATION; PATHOLOGY; RETROSPECTIVE STUDY; RISK FACTOR;

ADULT; AGE FACTORS; AGED; CARDIOMYOPATHY, HYPERTROPHIC; CARRIER PROTEINS; FEMALE; GENOTYPE; HEART FAILURE; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MUTATION; PHENOTYPE; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS;

EID: 84928929874     PISSN: 09145087     EISSN: 18764738     Source Type: Journal    
DOI: 10.1016/j.jjcc.2014.07.010     Document Type: Article

References (22)

1. Spirito P., Seidman C.E., McKenna W.J., Maron B.J. The management of hypertrophic cardiomyopathy. N Engl J Med 1997, 336:775-785.
2. Maron B.J., McKenna W.J., Danielson G.K., Kappenberger L.J., Kuhn H.J., Seidman C.E., Shah P.M., Spencer W.H., Spirito P., Ten Cate F.J., Wigle E.D. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol 2003, 42:1687-1713.
3. Maron B.J., Maron M.S. Hypertrophic cardiomyopathy. Lancet 2013, 381:242-255.
4. Maron B.J., Braunwald E. Evolution of hypertrophic cardiomyopathy to a contemporary treatable disease. Circulation 2012, 126:1640-1644.
5. Arad M., Seidman J.G., Seidman C.E. Phenotypic diversity in hypertrophic cardiomyopathy. Hum Mol Genet 2002, 11:2499-2506.
6. Kimura A. Molecular etiology and pathogenesis of hereditary cardiomyopathy. Circ J 2008, 72:A38-A48.
7. Maron B.J., Maron M.S., Semsarian C. Genetics of hypertrophic cardiomyopathy after 20 years. J Am Coll Cardiol 2012, 60:705-715.
8. Otsuka H., Arimura T., Abe T., Kawai H., Aizawa Y., Kubo T., Kitaoka H., Nakamura H., Nakamura K., Okamoto H., Ichida F., Ayusawa M., Nunoda S., Isobe M., Matsuzaki M., et al. Prevalence and distribution of sarcomeric gene mutations in Japanese patients with familial hypertrophic cardiomyopathy. Circ J 2012, 76:453-461.
9. Lopes L.R., Rahman M.S., Elliott P.M. A systematic review and meta-analysis of genotype-phenotype associations in patients with hypertrophic cardiomyopathy caused by sarcomeric protein mutations. Heart 2013, 99:1800-1811.
10. Charron P., Carrier L., Dubourg O., Tesson F., Desnos M., Richard P., Bonne G., Guicheney P., Hainque B., Bouhour J.B., Mallet A., Feingold J., Schwartz K., Komajda M. Penetrance of familial hypertrophic cardiomyopathy. Genet Couns 1997, 8:107-114.
11. Dimitrow P.P., Czarnecka D., Strojny J.A., Kawecka-Jaszcz K., Dubiel J.S. Impact of gender on the left ventricular cavity size and contractility in patients with hypertrophic cardiomyopathy. Int J Cardiol 2001, 77:43-48.
12. Maron B.J., Casey S.A., Hyrrell D.G., Aeppli D.M. Relation of left ventricular thickness to age and gender in hypertrophic cardiomyopathy. Am J Cardiol 2003, 91:1195-1198.
13. Olivotto I., Maron M.S., Adabag A.S., Casey S.A., Vargiu D., Link M.S., Udelson J.E., Cecchi F., Maron B.J. Gender-related differences in the clinical presentation and outcome of hypertrophic cardiomyopathy. J Am Coll Cardiol 2005, 46:480-487.
14. Kubo T., Kitaoka H., Okawa M., Hirota T., Hayato K., Yamasaki N., Matsumura Y., Yabe T., Doi Y.L. Gender-specific differences in the clinical features of hypertrophic cardiomyopathy in a community-based Japanese population: results from Kochi RYOMA study. J Cardiol 2010, 56:314-319.
15. Kubo T., Kitaoka H., Okawa M., Matsumura Y., Hitomi N., Yamasaki N., Furuno T., Takata J., Nishinaga M., Kimura A., Doi Y.L. Lifelong left ventricular remodeling of hypertrophic cardiomyopathy caused by a founder frameshift deletion mutation in the cardiac myosin-binding protein C gene among Japanese. J Am Coll Cardiol 2005, 46:1737-1743.
16. Hirota H., Kubo T., Kitaoka H., Hamada T., Baba Y., Hayato K., Okawa M., Yamasaki N., Matsumura Y., Tabe T., Doi Y.L. A novel cardiac myosin-binding protein C S297X mutation in hypertrophic cardiomyopathy. J Cardiol 2010, 56:59-65.
17. Hitomi N., Kubo T., Kitaoka H., Hirota T., Hamada T., Hoshikawa E., Hayato K., Okawa M., Kimura A., Doi Y.L. A frameshift deletion mutation in the cardiac myosin-binding protein C gene associated with dilated phase of hypertrophic cardiomyopathy and dilated cardiomyopathy. J Cardiol 2010, 56:189-196.
18. Kitaoka H., Kubo T., Okawa M., Takenaka N., Baba Y., Yamasaki N., Matsumura Y., Furuno T., Doi Y.L. Plasma metalloproteinase levels and left ventricular remodeling in hypertrophic cardiomyopathy in patients with an identical mutation. J Cardiol 2011, 58:261-265.
19. Dimitrow P.P., Czarnecka D., Jaszcz K.K., Dubiel J.S. Sex differences in age at onset of symptoms in patients with hypertrophic cardiomyopathy. J Cardiovasc Risk 1997, 4:33-35.
20. Lin C.L., Chiang C.W., Shaw C.K., Chu P.H., Chang C.J., Ko Y.L. Gender differences in the presentation of adult obstructive hypertrophic cardiomyopathy with resting gradient: a study of 122 patients. Jpn Circ J 1999, 63:859-864.
21. Page S.P., Kounas S., Syrris P., Christiansen M., Frank-Hansen R., Andersen P.S., Elliott P.M., McKenna W.J. Cardiac myosin binding protein-C mutations in families with hypertrophic cardiomyopathy: disease expression in relation to age, gender, and long term outcome. Circ Cardiovasc Genet 2012, 5:156-166.
22. Regitz-Zagrosek V. Therapeutic implications of the gender-specific aspects of cardiovascular disease. Nat Rev Drug Discov 2006, 5:425-438.